Balyasny Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-313,796
| Closed | -$14.5M | – | 1609 |
|
|
2019
Q2 | $14.5M | Buy |
+313,796
| New | +$14.5M | 0.09% | 268 |
|
|
2019
Q1 | – | Sell |
-31,579
| Closed | -$450K | – | 1648 |
|
|
2018
Q4 | $450K | Sell |
31,579
-374,309
| -92% | -$5.33M | ﹤0.01% | 1023 |
|
|
2018
Q3 | $6.17M | Buy |
405,888
+367,640
| +961% | +$5.59M | 0.03% | 509 |
|
|
2018
Q2 | $642K | Sell |
38,248
-279,360
| -88% | -$4.69M | ﹤0.01% | 1087 |
|
|
2018
Q1 | $5.18M | Sell |
317,608
-1,505,196
| -83% | -$24.6M | 0.02% | 585 |
|
|
2017
Q4 | $23.3M | Buy |
1,822,804
+1,479,245
| +431% | +$18.9M | 0.07% | 320 |
|
|
2017
Q3 | $4.23M | Sell |
343,559
-375,565
| -52% | -$4.62M | 0.02% | 632 |
|
|
2017
Q2 | $6.02M | Buy |
719,124
+560,124
| +352% | +$4.69M | 0.02% | 578 |
|
|
2017
Q1 | $1.42M | Sell |
159,000
-1,230,775
| -89% | -$11M | 0.01% | 840 |
|
|
2016
Q4 | $12.2M | Buy |
+1,389,775
| New | +$12.2M | 0.07% | 346 |
|
|
2016
Q3 | – | Sell |
-32,090
| Closed | -$114K | – | 1223 |
|
|
2016
Q2 | $114K | Sell |
32,090
-17,700
| -36% | -$62.9K | ﹤0.01% | 923 |
|
|
2016
Q1 | $147K | Buy |
49,790
+1,430
| +3% | +$4.22K | ﹤0.01% | 962 |
|
|
2015
Q4 | $204K | Sell |
48,360
-22,090
| -31% | -$93.2K | ﹤0.01% | 954 |
|
|
2015
Q3 | $321K | Sell |
70,450
-2,740
| -4% | -$12.5K | ﹤0.01% | 733 |
|
|
2015
Q2 | $528K | Buy |
+73,190
| New | +$528K | ﹤0.01% | 620 |
|
|
2014
Q2 | – | Sell |
-2,070,626
| Closed | -$9.73M | – | 644 |
|
|
2014
Q1 | $9.73M | Buy |
2,070,626
+868,426
| +72% | +$4.08M | 0.11% | 195 |
|
|
2013
Q4 | $6.02M | Buy |
1,202,200
+89,516
| +8% | +$448K | 0.08% | 238 |
|
|
2013
Q3 | $6.92M | Buy |
1,112,684
+554,744
| +99% | +$3.45M | 0.09% | 243 |
|
|
2013
Q2 | $2.53M | Buy |
+557,940
| New | +$2.53M | 0.04% | 318 |
|